Articles tagged with Small Molecules
Researchers at Purdue University have developed a novel cancer immunotherapy compound that targets the enzyme TC-PTP, found in both cancer cells and T cells. Deleting this enzyme promotes antigen presentation, alerting the immune system to tumor cells, while stimulating T-cell activation enhances their ability to fight and destroy tumors.
Researchers have identified a small molecule that reverses four types of chronic pain in animal studies without troublesome side effects. The compound, CBD3063, binds to the inner region of a calcium channel, indirectly regulating its activity and reducing neurotransmitter release.
The Precision Vaccines Program at Boston Children's Hospital has been awarded a $9 million NIH contract to develop a small molecule adjuvant to enhance the effectiveness of flu vaccines. The collaboration with Inimmune aims to increase the body's immune response to vaccines and protect vulnerable populations.
Researchers have developed a dinuclear ruthenium complex that efficiently reduces CO2 to carbon monoxide with over 99% selectivity. The catalyst's self-photosensitizing properties enhance its stability under reaction conditions, allowing it to drive the CO2 reduction process even at low CO2 concentrations.
The UCLA-led team has developed a solution to improve cryo-electron microscopy's imaging capabilities for smaller protein molecules, enabling higher-resolution images. This advance is expected to help researchers identify specific locations on proteins that can be targeted for therapeutic purposes.
A small molecule drug improved the fitness of hematopoietic stem cells used in cell transplants, potentially enhancing the success of procedures like ex vivo gene therapy. The study found that targeting extracellular vesicles relieved stress on cells outside the body, improving their performance when transplanted back in.
Researchers at Rice University have developed a non-invasive gene delivery technique using ultrasound to efficiently deliver clinically used gene therapy vectors throughout the brain. The study, published in Gene Therapy, shows that opening more sites within targeted regions improves gene delivery efficiency.
Researchers create adenine base editor with 'on/off' switch, reducing off-target edits by over 70% and increasing accuracy of on-target edits. The tool has potential to correct nearly half of disease-causing point mutations in human genome.
Researchers have developed a new method to adapt Ritalin to tackle cocaine abuse, overcoming a chemical hurdle that previously limited the potential of methylphenidate derivatives. This breakthrough could lead to more effective treatment options for cocaine addiction.
The US Army Medical Materiel Development Activity has developed a shelf-stable treatment for snakebite envenoming that is safe, easy to use, and independent of snake species. Clinical trials are ongoing in the US and India, with pre-clinical studies suggesting its potential use worldwide.
Researchers at the University of Missouri have developed a new method using nanopores to advance discoveries in neuroscience and medical applications. The technique allows for real-time detection of dynamic aptamer-small molecule interactions, which can aid in understanding DNA and RNA diseases and drug discovery.
Gray mold is a fungus that causes billions of dollars in crop losses each year, but researchers have discovered a way to control it without using toxic chemicals. The discovery reveals that gray mold uses lipid 'bubbles' to deliver RNA molecules that silence plant immune systems.
A team from the University of Ottawa has developed a comprehensive screening platform and cellular interrogation tool to facilitate novel drug discovery targeting various human diseases. The 'Tango-Trio' platform can identify small molecule modulators for orphan GPCRs, which have significant untapped therapeutic potential.
Researchers have identified LP-284 as a novel acylfulvene compound with anti-tumor activity against non-Hodgkin's lymphoma. The compound exerts nanomolar potency in 15 NHL cell lines and prolongs survival of mantle cell lymphoma xenograft mice, making it a potential therapeutic option for patients with HR or TC-NER deficiency.
A team of researchers from China and the UK has developed new ways to optimise the production of solar fuels by creating novel photocatalysts. These photocatalysts, such as titanium dioxide with boron nitride, can absorb more wavelengths of light and produce more hydrogen compared to traditional methods.
Researchers at the University of Helsinki discovered a small molecule that inhibits cytokine protein formation, alleviating rheumatoid arthritis symptoms in mice. This breakthrough enables the rational design of novel molecules for disease prevention and treatment.
Researchers propose a new bonding theory that illustrates how each boron atom satisfies the octet rule and how alternating σ bonds further stabilize the 2D sheet. The theory introduces a new form of resonance, allowing delocalization of σ electrons within the plane.
Scripps Research scientists develop a new strategy to identify small molecules that can alter protein function, offering a promising path for discovering targeted cancer drugs. By comparing how mirror image versions of small molecules impact clusters of proteins, they identified potential new drug targets such as MY-1B and EV-96.
Researchers at Colorado State University have created a new chemical strategy to deliver universal dynamic crosslinkers into mixed plastic streams, transforming them into viable new polymers that can be turned into higher-value materials. The method makes post-consumer plastics usable as a new kind of material with useful properties.
Researchers found that CUDC-907 selectively induces apoptosis in cells driven to senesce by p53 expression. The compound showed senolytic properties in different models of stress-induced senescence, depending on its inhibitory effects on HDACs and PI3K.
Researchers explored multicomponent electrocatalysts for activating and converting inert bonds in CO2 and N2. Three models were developed: Type I, II, and III, offering advantages in stability, activity, and reaction processes. Future directions involve scaling up and integrating these processes into industrial applications.
Researchers at Argonne National Laboratory and University of Chicago developed a hybrid simulation process using IBM quantum computers to solve electronic structure problems. The new method uses classical processing to mitigate noise generated by the quantum computer, paving the way for future improvements.
A novel small molecule, MK-8722, has been shown to trigger improved muscle health in mice with muscular dystrophy by activating AMPK. This finding highlights the potential of this class of AMPK activators as a cost-effective and efficacious method for DMD treatment.
Researchers have developed a new host material that enhances the efficiency of organic light-emitting diodes (OLEDs) by reducing concentration quenching and increasing thermally activated delayed fluorescence. This breakthrough could lead to improved displays, lighting, and medical treatments.
A small molecule discovered by University of Houston researchers could potentially shorten the course of SARS-CoV-2 infection, offering a new alternative treatment option for COVID-19. The compound, CD04872SC, has shown promise in neutralizing the virus and its variants Delta and Omicron.
Researchers have found a potential treatment for osteoarthritis by targeting the GP130 immune receptor, which causes hyper-inflammation in joints. The new compound R805/CX-011 showed promising results in animal studies, reducing joint pain and stiffness, and may lead to Phase 1 and 2A clinical trials.
Researchers developed a small-molecule drug that limits magnesium transport into cellular power plants, resulting in skinny, healthy mice. The findings hold significant implications for preventing cardiometabolic diseases like heart attack and stroke, as well as reducing liver cancer risk.
Researchers have developed a super-resolution microscope with a spatio-temporal precision of one nanometer per millisecond using the MINFLUX technique. This allows them to observe tiny movements of single proteins, including the stepping motion of kinesin-1 along microtubules while consuming ATP.
Hollings researchers create small molecule that targets CD38 enzyme activity, stimulating proliferation of natural killer cells and enhancing anti-cancer activity. The compound has potential as an adjuvant therapy to boost effects of existing treatments and reduce resistance to monoclonal antibodies.
Researchers from Rice University have developed a new approach to control gene expression using proteolysis targeting chimeras (PROTACs). By reengineering the PROTAC molecular infrastructure, they demonstrated the ability to achieve chemically induced dimerization (CID), allowing for precise control over gene activation in specific loc...
Scientists have identified small molecules that can target the 'Achilles' heel' of SARS-CoV-2, a less mutation-prone segment of the spike protein. These compounds could serve as a starting point for developing effective treatments for COVID-19.
Researchers developed a 'scanning and direct derivatization' method to target polymyxin, an antibiotic of last resort, for treating diseases resistant to conventional drugs. The method generated hundreds of peptide derivatives with varying effects, accelerating drug development.
Dimethyl sulfide levels have increased in Arctic air over the past five decades, according to a study led by Hokkaido University. The team tracked the rise in emissions through measurements of methane sulfonic acid in Greenland ice cores, finding higher levels between 2002 and 2014.
A research team led by Dr. Eddie Ma Chi-him identified a therapeutic small molecule M1 that increases mitochondrial dynamics and sustains long-distance axon regeneration, restoring visual functions in mice. Regenerated axons elicited neural activities and survived for four weeks after optic nerve injury.
A team of researchers from Japan has developed a single purely organic neutral molecule with an incomplete oxidation state for the first time. The new molecule exhibits multi-step phase transitions and crossover caused by intra- and intermolecular electronic interactions, leading to unique strongly correlated electron properties.
Researchers at Rice University have developed a new fluorescent dye that can cross the blood-brain barrier, allowing for noninvasive brain imaging and differentiation between healthy tissue and tumor cells. The dye's long-lasting fluorescence enables stable imaging over extended periods.
Researchers discovered that 15-deoxy-prostamide-J2 induces ER stress-mediated apoptosis selectively in tumor cells, reducing melanoma growth. The molecule activates PERK, IP3R, and the mitochondrial permeability transition pore, leading to cell death.
Researchers at Ruhr University Bochum have developed a novel synthesis process that converts carbon monoxide into anionic ketenes, which can be isolated and used as defined reagents. This approach avoids the use of expensive or toxic metals, making it a promising avenue for sustainable chemistry.
Researchers at Rice University have developed a multiplex base-editing platform that significantly improves the pace of new drug discovery by inducing fungi to produce more bioactive compounds. The technique has been deployed as a tool for mining fungal genomes for medically useful compounds, reducing research timeline by over 80%.
Researchers at Argonne National Laboratory have developed a way to rotate a single molecule, europium complex, clockwise or counterclockwise on demand. This technology could lead to breakthroughs in microelectronics, quantum computing and more.
A new machine learning model developed by Aalto University researchers can identify small molecules with unprecedented accuracy, distinguishing between mirror image molecules. This breakthrough has significant implications for understanding metabolic disorders, such as diabetes, and identifying micropollutants in the environment.
An interdisciplinary team from Erlangen has found a new treatment for Huntington's disease by accelerating the degradation of a specific messenger molecule necessary for protein synthesis. This reduces the huntingtin level in patients, offering new hope for long-term implementation of RNA-modifying approaches for fatal diseases.
G-Quadruplex DNA structures play a crucial role in regulating genes and cell processes, but their visualization is challenging due to the dynamic nature of double standard DNA. Fluorescence-active small molecule probes have emerged as a real-time visualization method, enabling researchers to detect G-quadruplexes with high selectivity.
A new review paper discusses the role of CDK4 in regulating the cell cycle and its involvement in cancer. The study highlights the importance of CDK4/6 inhibitors as treatments for ER+ breast cancer and their potential utility in multiple tumor types.
Researchers at the University Hospital Bonn have discovered a new function of CRISPR/Cas9 gene scissors, which produce small signal molecules that bind to proteins, activating an emergency response. This discovery opens up new possibilities for treating diseases using CRISPR technology.
Researchers have created a chemical tag that can be added to drugs, allowing them to enter blood circulation via the intestines. The tag, called EPP6, is a neutral peptide that can deliver drugs orally, potentially replacing injections for diabetes and cancer patients.
Researchers at the University of Illinois developed an AI-powered system that uses a molecule-making machine to find optimal reaction conditions for synthesizing chemicals. The system doubled the average yield of a challenging class of reactions, paving the way for faster innovation and automation in biomedical and materials research.
Researchers developed a small peptide that can directly kill bacteria and trigger plant defense tactics to prevent diseases like almond leaf scorch. The treatment significantly reduces pathogen population and disease symptoms, making it a promising approach for sustainable crop protection.
Scientists at the University of Florida have identified two small molecules that inhibit precancerous cell progression and reverse a key process involved in pancreatic cancer progression. This discovery could lead to earlier treatments and improved survival rates for patients with pancreatic cancer.
Researchers have identified a small molecule drug, SHP656, that can target the circadian clock proteins responsible for glioblastoma's recurrence and spread. The drug has shown promise in reducing cancer stem cell growth without harming normal stem cells.
A recent study published in Nature Communications has found a strong connection between the gut microbiome and certain blood metabolites. The research, led by Uppsala University, analyzed fecal and blood samples from over 8,500 participants in the SCAPIS study, identifying novel associations between gut bacteria and plasma metabolite s...
Researchers at the Max Born Institute have used novel ultrashort soft X-ray spectroscopy to study the fate of molecular nitrogen when an electron is kicked out. They found that the B state has a similar degree of excitation as the X state, contradicting previous models. Instead, a coherent interplay between light fields enables lasing ...
Tel Aviv University researchers discovered that skin cancer cells interact with astrocytes in the brain, promoting metastasis. By inhibiting this interaction using existing treatments, they delayed the spread of melanoma to the brain by 60-80%. This breakthrough has implications for treating advanced-stage melanoma.
Scientists at Kyushu University have developed organic molecules that align in the same direction, creating a 'giant surface potential' when evaporated onto a surface. This alignment leads to a significant electric field, which can improve OLED efficiency and open new routes for realizing devices that convert vibrations into electricity.
Researchers found that cells in diseased connective tissue lose their ability to reorder DNA information correctly, leading to cell dysfunction. The study suggests that epigenetic treatments could restore healthy genome organization and may be effective treatments for conditions affecting dense tissues.
Researchers at Washington University in St. Louis found that cancer cells metabolize glucose in their mitochondria, following conventional biochemical patterns. The study suggests that limiting glucose uptake may not be an effective strategy to target cancer cells, and glucose metabolism may need to be reevaluated as a therapeutic target.
Researchers developed a small molecule that effectively controls tumor growth by inhibiting PD-1/PD-L1 binding, overcoming accessibility and cost issues of existing antibody treatments. The new molecule has advantages in terms of affordability and oral administration, making immunotherapy more accessible to all cancer patients.
A University of Illinois research effort has accelerated imaging techniques to visualize small molecules clearly, enabling better understanding of their chemical processes and synthesis. The team's discovery unlocks potential in everyday life applications, from plastics to pharmaceuticals.
Researchers have discovered eight potential leukemia-killing compounds that target mitochondria, inducing mitophagy to weaken cancer cells. The compounds showed significant synergy with existing chemotherapy drugs, offering a deadly one-two punch against leukemia.
Researchers used chemoproteomics to profile 53 HDAC drugs and found many had additional targets beyond their intended HDACs. The study identified MBLAC2 as a common off-target protein that affects extracellular vesicle accumulation.